These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 24033533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei.
    Clarkson KA, Porter CK, Talaat KR, Frenck RW, Alaimo C, Martin P, Bourgeois AL, Kaminski RW.
    mSphere; 2021 Aug 25; 6(4):e0012221. PubMed ID: 34259559
    [Abstract] [Full Text] [Related]

  • 10. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis.
    Mitra S, Chakrabarti MK, Koley H.
    Vaccine; 2013 Jun 28; 31(31):3163-73. PubMed ID: 23684822
    [Abstract] [Full Text] [Related]

  • 11. Protection against shigellosis caused by Shigella dysenteriae serotype 4 in guinea pigs using Escherichia albertii DM104 as a live vaccine candidate strain.
    Chowdhury FM, Rahman MZ, Sarkar MMH, Rabbi F, Khan SI, Ahsan CR, Birkeland NK.
    Acta Microbiol Immunol Hung; 2017 Jun 01; 64(2):151-164. PubMed ID: 28597684
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a multicomponent live, attenuated Shigella flexneri vaccine.
    DeLaine BC, Wu T, Grassel CL, Shimanovich A, Pasetti MF, Levine MM, Barry EM.
    Pathog Dis; 2016 Jul 01; 74(5):. PubMed ID: 27106253
    [Abstract] [Full Text] [Related]

  • 13. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.
    Citiulo F, Necchi F, Mancini F, Rossi O, Aruta MG, Gasperini G, Alfini R, Rondini S, Micoli F, Rappuoli R, Saul A, Martin LB.
    PLoS Negl Trop Dis; 2021 Oct 01; 15(10):e0009826. PubMed ID: 34644291
    [Abstract] [Full Text] [Related]

  • 14. Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice.
    Mitra S, Barman S, Nag D, Sinha R, Saha DR, Koley H.
    FEMS Immunol Med Microbiol; 2012 Nov 01; 66(2):240-50. PubMed ID: 22762732
    [Abstract] [Full Text] [Related]

  • 15. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.
    McKenzie R, Walker RI, Nabors GS, Van De Verg LL, Carpenter C, Gomes G, Forbes E, Tian JH, Yang HH, Pace JL, Jackson WJ, Bourgeois AL.
    Vaccine; 2006 May 01; 24(18):3735-45. PubMed ID: 16095766
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM, Wang J, Wu T, Davis T, Levine MM.
    Vaccine; 2006 May 01; 24(18):3727-34. PubMed ID: 16169130
    [Abstract] [Full Text] [Related]

  • 17. A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge.
    Ndungo E, Randall A, Hazen TH, Kania DA, Trappl-Kimmons K, Liang X, Barry EM, Kotloff KL, Chakraborty S, Mani S, Rasko DA, Pasetti MF.
    mSphere; 2018 Aug 01; 3(4):. PubMed ID: 30068560
    [Abstract] [Full Text] [Related]

  • 18. Development of a new guinea-pig model of shigellosis.
    Barman S, Saha DR, Ramamurthy T, Koley H.
    FEMS Immunol Med Microbiol; 2011 Aug 01; 62(3):304-14. PubMed ID: 21539623
    [Abstract] [Full Text] [Related]

  • 19. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ.
    Clin Vaccine Immunol; 2017 Dec 01; 24(12):. PubMed ID: 29046309
    [Abstract] [Full Text] [Related]

  • 20. Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex.
    Turbyfill KR, Clarkson KA, Vortherms AR, Oaks EV, Kaminski RW.
    mSphere; 2018 Dec 01; 3(2):. PubMed ID: 29600284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.